Novel ADC targets in Pediatric Glioma

We propose to access the mRNA expression data in the CBTN to identify novel targets for a promising type of therapeutic called an antibody drug conjugate. Such therapeutics have performed exceptionally well in adult cancers provided that a strong cell-surface receptor can be identified. We will seek to identify such a receptor for the brain tumor called pediatric lower grade glioma.